Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Unknown 1

Sponsor Class

INDUSTRY 1

Study Type

Interventional 1

Sponsor

Cancer Type

Other 1Head & Neck 1Gastrointestinal 1

Conditions

Stomatognathic Diseases 1Stomatitis 1Neoplasms by Site 1Neoplasms 1Mucositis 1Mouth Diseases 1Head and Neck Neoplasms 1Gastrointestinal Diseases 1Gastroenteritis 1Digestive System Diseases 1

Interventions

Resistance Training 4Nutrition Assessment 4naloxegol 3Surveys and Questionnaires 3Exercise 3alvimopan 2Therapeutics 2Psychiatric Rehabilitation 2Oxygen 2Nutritional Status 2Mouthwashes 2Morphine 2Ketamine 2Interviews as Topic 2Fibroblast Growth Factor 7 2Counseling 2semaglutide 1naldemedine 1methylnaltrexone 1ma zi ren wan 1kang-lai-te 1hydrated silica gel-based toothpaste 1golotimod 1dexamethasone acetate 1dexamethasone 21-phosphate 1calcium phosphate 1auricularum 1aluminum hydroxide, magnesium hydroxide, drug combination 1Weights and Measures 1Walking 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Neoplasms × golotimod × Other × Clear all
NCT01247246 2014-05-26

Study to Evaluate the Efficacy and Safety of Three Different Doses of SCV 07 in Attenuating Oral Mucositis in Subjects With Head and Neck Cancer

SciClone Pharmaceuticals

Phase 2 Unknown
160 enrolled
GastrointestinalHead & NeckOther

Digestive System Diseases, Gastroenteritis, Gastrointestinal Diseases, Head and Neck Neoplasms, Stomatognathic Diseases, Mouth Diseases, Neoplasms, Neoplasms by Site, Stomatitis, Mucositis

Data powered by HemOnc (CC BY 4.0) Colophon âš¡